Jump to content

Cary

Members
  • Posts

    197
  • Joined

  • Last visited

  1. Cary

    6 YEARS!!!!

    Sorry about the confusion, something must have happened to my profile between my last post in Feb 2005 and now. My Father passed away in Nov. 2004 from sepsis. Everything was going fine cancer wise for the most part though, just some low dose treatments to keep everything small/gone. I can't seem to update my email address in my profile, does anyone have a trick on how to get it to work?
  2. Cary

    6 YEARS!!!!

    another 6 months and you could have just retired Congrats!! I knew you would make it!!
  3. I don't know if it's right or not, but a lot of places are actually selling custom braclets/wristbands. http://froogle.google.com/froogle?q=cus ... +bracelets Cary
  4. Cary

    Cary's Dad-updated

    Everyone, I just wanted to thank all of you for your kind and heartfelt responses, I'm sorry I haven't been able to post sooner, but it's been pretty hectic around here, the relatives have already started arriving and will be here for the next couple of weeks(my dads funeral is on Thursday). I also have limited access to the internet for a few more weeks, but I will try and keep all of you updated. Thank you, Cary
  5. Kitty, Is you father experiencing mini-strokes or mini-seizures? My dad was having mini-seizures and declined in health over a couple of weeks. He eventually had a full seizure and became completely paralyzed (for 2 days) before they found his brain tumors back in 2003. He received WBR for his 21 brain mets(1cm-2cm each) and currently has no evidence of disease. You may want to get a second opinion. Cary
  6. Geoff, That is great news, if you would like first hand knowledge on the vaccine therapy, i know a lady that flies to Germany, to get treatments from Dr. Nesslehut. She has mentioned in the past, that she would be willing to correspond with others that have questions. I believe her secondary Oncologist is Dr. Chang also. Cary
  7. Marisa, Sounds interesting. I think Karel and his daughters are from Australia, I wonder if they have heard/looked into this treatment and what they think of it. Cary
  8. Cary

    IP6

    Karel, I believe it's from the Journal of Endocrinology (June 2004). I am not sure if the full version is available on-line. I was actually emailed the "accepted preprint" months ago, then received the published version the same way. Cary
  9. I know i must have posted this article before, but i can't seem to find it. When my dad was doing WBR we cut out most of his supplements and just happened to leave his salmon oil and his homemade vegetable drink along with his other "off label" cancer treatments. Hopefully this combination made the difference, since he has very little if any permanent damage. Anticancer Res. 1999 Nov-Dec;19(6C):5583-6. (Abstract) Increased survival in brain metastatic patients treated with stereotactic radiotherapy, omega three fatty acids and bioflavonoids Gramaglia A, Loi GF, Mongioj V, Baronzio GF National Cancer Institute, Milan, Italy. Stereotactic radiotherapy represents a method to effectively treat brain metastases with high precision and with high doses. Few acute toxicities are associated with stereotactic radiotherapy, however delayed reactions may occur and after six months, 20% of patients can develop radionecrosis. To avoid this adverse effect, in patients with metastases localized in critical brain areas, a supplementation of Omega three fatty acids and bioflavonoids has been used. At the end of 1997, we initiated a series of retrospective studies to test the efficacy of stereotactic radiotherapy on 405 patients, and the prognostic importance on survival of various variables among which this type of supplementation. From the comparison of various survival curves with the Cox multivariate analysis, it emerged that the patients using this supplementation had a decreased risk ratio and an improvement in survival time. A decreased number of radionecrosis was noted. We suggest their use as radioprotectors. PMID: 10697622 [PubMed - indexed for MEDLINE] Source: http://www.ncbi.nlm.nih.gov/entrez/quer ... t=Abstract
  10. MJ, Yes you can, I will have to pull some of my old research and post/repost. Radiation is actually more effective/less side effects while on TM(low copper levels). Cary
  11. Cary

    IP6

    Alisa, thanks for the link, i will check it out. I bought IP6 a couple of days ago from the place Karel mentioned. I am headed over to vitaminshoppe.com to compare prices. Cat: it's been mailed. Cary
  12. Cary

    IP6

    Cat, My father has been on Tetrathiomolybdate since February 03. I don't think there are any clinical trials currently being conducted, but it has been available "off-label" since basically the first clinical trial data was published. It a pretty simple therapy. I do have the latest research paper that was published, but unfortunately it's in PDF format. If anyone wants the paper though, i will email it as an attachment. I have posted all the older articles on Tetrathiomolybdate so you should be able to do a search for "copper" on this board. Alisa: I went to nutricology a few days ago, looking for IP-6 and i can't seem to find it on their list of products, do you have a direct link to the IP6 page. Cary
  13. Hi Geoff, Dendritic cell vaccines are currently available in Germany. The info below is from a lady that is currently flying to Germany to receive treatments. I find it interesting that the German and U.S. researchers are in such close contact(I think that is good news). If you have any questions let me know. They are contemplating a new 'joint' web site with some U.S. doctor(s) that may help some of you who have so many questions and may also lay out more clearly all the expenses involved in the treatment, the odds of success, the experiences in your own kind of cancer, etc. But this is in the future. They are always comparing and working with other dendritic cell research groups throughout Europe, and are in contact with the U.S. groups as well. Because of the difference in philosophical approach between the German "E Commission" and the U.S. FDA, they are legally able to treat patients (for whom there is no current curative treatment) in other than a clinical trial setting. The advantage here is two fold: the patient does not need to fit a rigidly defined protocol to qualify for a specific trial AND because there is no rigid protocol, they can tailor the fine details of each treatment to each individual based on their experience with that patient's kind of cancer and disease stage. In most cases, one can continue with one's other treatments including most alternative and complementary treatments -- but of course one must first check with them to be sure there is no problem in doing so. They, in fact, highly recommend that their patients take certain supplements/vitamins etc. to strengthen the immune systems and/or increase the effect of the dendritic cell vaccine. Unlike many dendritic cell treatments, they can treat patients who do NOT have fresh tumor tissue although, in many (most?) cases they like to have fresh tumor tissue to use in combination with the patient's own blood. But for patients like me, who have not been able to get fresh samples of the metastatic lesions, this ability to work even without tumor lysates is a plus.
  14. The Journal of Clinical Investigation is pleased to announce FREE ACCESS to its electronic archive from 1924 through 2004. Full PDF versions of all articles are now available through PubMed Central. View the archive at: http://www.pubmedcentral.com/tocrender. ... ournal=120 The JCI is the ONLY high-impact journal that provides FREE ACCESS to all its articles from the day of publication. The JCI was the first top-tier journal to successfully launch free access in 1996, and we remain committed to free-access publication. Sincerely, Ushma Savla, Ph.D. Executive Editor, The Journal of Clinical Investigation 2003 Impact Factor: 14.307 View the current issue at: http://www.jci.org
  15. Sounds promising. Cary http://carcin.oupjournals.org/cgi/conte ... t/bgh232v1 Abstract A significant anti-cancer activity of the naturally occurring carbohydrate inositol hexaphosphate (IP6) has been reported against numerous cancer models. Since tumors require angiogenesis for growth and metastasis, we hypothesize that IP6 reduces tumor growth by inhibiting angiogenesis. Because angiogenesis depends on the interaction between endothelial and tumor cells, we investigated the effect of IP6 on both. IP6 inhibited the proliferation and induced the differentiation of endothelial cells in vitro; the growth of bovine aortic endothelial cells (BAECs) evaluated by MTT proliferation assay was inhibited in a dose-dependent manner (IC50 = 0.74 mM). The combination of IP6 and vasostatin, a calreticulin fragment with anti-angiogenic activity, was synergistically superior in growth inhibition than either compound. IP6 inhibited human umbilical vein endothelial cell (HUVEC) tube formation (in vitro capillary differentiation) on a reconstituted extracellular matrix, Matrigel, and disrupted pre-formed tubes. IP6 significantly reduced basic fibroblast growth factor (bFGF)-induced vessel formation (p < 0.01) in vivo in Matrigel plug assay. Exposure of HepG2, a human hepatoma cell line, to IP6 for 8 h, resulted in a dose-dependent decrease in the mRNA levels of vascular endothelial growth factor (VEGF), as assessed by RT-PCR. IP6 treatment of HepG2 cells for 24 h also significantly reduced the VEGF protein levels in conditioned medium, in a concentration-dependent manner (p = 0.012). Thus, IP6 has an inhibitory effect on induced angiogenesis."
×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.